Preclinical CRO Market Dynamics and Forecasts: 2025-2033 Strategic Insights
The preclinical CRO market is booming, projected to reach $12.65 billion by 2033 at a CAGR of 7.44%. This comprehensive analysis explores market drivers, trends, restraints, key players (Charles River, Eurofins, ICON), and regional insights, highlighting the growing demand for PDO/PDX models and specialized services in drug development.